|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.17 CNY | -1.54% |
|
-5.28% | -24.23% |
Tongling Jieya Biologic Technology Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 622.59 million compared to CNY 666.56 million a year ago. Net income was CNY 115.2 million compared to CNY 140.97 million a year ago.
Basic earnings per share from continuing operations was CNY 1.42 compared to CNY 1.74 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.23% | 298M | |
| +6.29% | 44.43B | |
| -3.39% | 18.89B | |
| -6.37% | 4.06B | |
| +3.08% | 3.61B | |
| +6.18% | 2.8B | |
| -21.40% | 1.44B | |
| +55.15% | 1.42B | |
| +15.20% | 933M | |
| +18.87% | 802M |
TONGLING JIEYA BIOLOGIC TECHNOLOGY CO., LTD. 
